2021 Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Avichai Shimoni Journal Br J Haematol.
2021 Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry Group Chronic Malignancies Working Party (CMWP) 1st listed author Juan-Carlos Hernández-Boluda Journal Am J Hematol.
2021 Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis Group Chronic Malignancies Working Party (CMWP) 1st listed author D McLornan Journal Bone Marrow Transplant.
2021 IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study Group Chronic Malignancies Working Party (CMWP) 1st listed author Sarah Lawless Journal Clin Lymphoma Myeloma Leuk.
2021 Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party Group Chronic Malignancies Working Party (CMWP) 1st listed author Patrick J Hayden Journal Bone Marrow Transplant.
2021 Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia Group Chronic Malignancies Working Party (CMWP) 1st listed author Johannes Schetelig Journal Front Immunol.
2021 Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Mitja Nabergoj Journal Bone Marrow Transplant.
2021 Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Laurent Garderet Journal Eur J Haematol.
2021 Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Giorgia Battipaglia Journal Bone Marrow Transplant.
2021 [CAR-T CELLS: How does the EBMT registry monitor European activities, identify hurdles and prepare for changes in regulations] Group Acute Leukemia Working Party (ALWP) Severe Aplastic Anaemia Working Party (SAAWP) Chronic Malignancies Working Party (CMWP) Cellular Therapy & Immunobiology Working Party (CTIWP) Inborn Errors Working Party (IEWP) 1st listed author Christian Chabannon Journal Bull Cancer.
2021 Pregnancy and pregnancy outcomes after hematopoietic stem cell transplantation in childhood: a cross-sectional survey of the EBMT Pediatric Diseases Working Party Group Paediatric Diseases Working Party (PDWP) 1st listed author T Diesch-Furlanetto Journal Hum Reprod.
2021 Defining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) Infectious Diseases Working Party (IDWP) 1st listed author Sara Ghorashian Journal Bone Marrow Transplant.